Seasonal influenza vaccination in Kenya: an economic evaluation using dynamic transmission modelling

被引：0
作者：
Jeanette Dawa
Gideon O. Emukule
Edwine Barasa
Marc Alain Widdowson
Omu Anzala
Edwin van Leeuwen
Marc Baguelin
Sandra S. Chaves
Rosalind M. Eggo
机构：
[1] University of Nairobi,KAVI
[2] Washington State University Global Health Programs Kenya Office,Institute of Clinical Research, College of Health Sciences
[3] Influenza Program,Center for Tropical Medicine, Nuffield Department of Medicine
[4] Centers for Disease Control and Prevention,Division of Global Health Protection
[5] Health Economics Research Unit,Division of Global Health Protection
[6] KEMRI Wellcome Trust Research Programme,Influenza Division
[7] University of Oxford,undefined
[8] Center for Global Health,undefined
[9] Centers for Disease Control and Prevention,undefined
[10] Center for Global Health,undefined
[11] Centers for Disease Control and Prevention,undefined
[12] Public Health England,undefined
[13] London School of Hygiene & Tropical Medicine,undefined
[14] Imperial College London,undefined
[15] National Center for Immunization and Respiratory Diseases,undefined
[16] US Centers for Disease Control and Prevention,undefined
来源：
BMC Medicine | / 18卷
关键词：
Dynamic transmission model; Economic evaluation; Cost-effectiveness; Influenza vaccine; Low- and middle-income countries; Vaccine timing; Vaccine target group;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 197 条
[1]  
Dawa JA(2018)National burden of hospitalized and non-hospitalized influenza-associated severe acute respiratory illness in Kenya, 2012-2014 Influenza Other Respir Viruses 12 30-37
[2]  
Chaves SS(2019)Developing a seasonal influenza vaccine recommendation in Kenya: process and challenges faced by the National Immunization Technical Advisory Group (NITAG) Vaccine. 37 464-472
[3]  
Nyawanda B(2013)Influenza vaccines in low and middle income countries: a systematic review of economic evaluations Hum Vaccines Immunotherapeutics. 9 1500-1511
[4]  
Njuguna HN(2013)Economic benefits of inactivated influenza vaccines in the prevention of seasonal influenza in children Hum Vaccines Immunotherapeutics 9 707-711
[5]  
Makokha C(2014)Results from the first six years of national sentinel surveillance for influenza in Kenya, July 2007-June 2013 PLoS One 9 e98615-2601
[6]  
Otieno NA(2016)Which influenza vaccine formulation should be used in Kenya? A comparison of influenza isolates from Kenya to vaccine strains, 2007-2013 Vaccine. 34 2593-834
[7]  
Dawa J(2017)Direct and indirect effects of influenza vaccination BMC Infect Dis 17 308-3462
[8]  
Chaves SS(2012)Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5 Value Health 15 828-1314
[9]  
Ba Nguz A(2012)Health and economic impact of the seasonal influenza vaccination programme in England Vaccine. 30 3459-926
[10]  
Kalani R(2013)Patients hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: exploring disease severity by virus type and subtype J Infect Dis 208 1305-385
12345678910